AndreaViecelli AustraliaUniversity of Queensland

AndreaViecelli
A/Prof Andrea Viecelli is an academic nephrologist at Princess Alexandra Hospital and was awarded her PhD in 2019 through the University of Queensland. As a clinical trialist of the Australasian Kidney Trials Network (AKTN) she plays a key role in designing and conducting international clinical trials in people with chronic kidney disease. As a Coordinating Committee member and Vascular Access Project Coordinator of the global SONG initiative, she is conducting clinical and qualitative research to establish standardised core outcome measures based on the shared priorities of patients, clinicians, researchers and policy makers from >100 countries to improve the relevance and reliability of kidney research to inform patient-centred care. As the recipient of a National Health and Medical Research Council (NHMRC) Emerging Leadership Investigator Grant and a Queensland Advancing Clinical Research Fellowship she currently pursues a program of clinical research to improve patient-important outcomes in haemodialysis. She is an Associate Editor for Kidney International Reports and Transplantation.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/349973996f480f7aaee8963fed0c71cc.jpg
First Name
Andrea
Last Name
Viecelli
Institution
Country.
Australia

Friday, February 7, 2025

Time Session
2:15 p.m.
3:45 p.m.
HIT1
AndreaViecelli Chair AustraliaUniversity of Queensland
VivekKumar Chair IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India
  • Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)
    HIT1-1
    RajivAgarwal Oral Abstract Presenter United States
  • Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
    HIT1-2
    BradRovin Oral Abstract Presenter United StatesThe Ohio State University
  • Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial
    HIT1-3
    KatherineTuttle Oral Abstract Presenter United StatesUniversity of Washington School of Medicine, Division of Nephrology
Brahmkamal Hall - Plenary Hall

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
SS2
AdeeraLevin Chair CanadaUniversity of British Columbia and Providence Health Care
AndreaViecelli Chair AustraliaUniversity of Queensland
Ajit singhNarula Chair India
  • Novel Trial Designs in Nephrology: Innovations and Structures
    SS2-01
    MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • What’s New in Clinical Trials?
    SS2-02
    DavidWheeler Speaker United KingdomUniversity College London
  • Value of Different Outcomes in the Era of Precision Medicine
    SS2-03
    RobertoPecoits Filho Speaker United StatesArbor Research Collaborative for Health
  • Conducting Trials in Low and Middle-income Countries
    SS2-04
    SoumitaBagchi Speaker IndiaProfessor, Department of Nephrology, All India Institute of Medical Sciences, New Delhi
  • Innovations in Pediatric Nephrology Discovery and Clinical Trial Conduct
    SS2-05
    ArpanaIyengar Speaker IndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE
  • Q&A
    SS2-06
Parijat Hall 201